Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research
National Institutes of Health (NIH), National Cancer Institute (NCI)
Total funding amount: approximately $700,000 for fiscal year 2026
Maximum budget per application: $150,000 per year for up to 2 years
Encourage revision applications from currently funded NCI R01 research projects
Incorporate new technical approaches or devices developed through the NCI IMAT program
Researchers in cancer studies
NCI-supported research communities
NIH funding
Research Project Grant (R01)
Recurring grant opportunity, updated from previous announcements
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations (including Small Businesses)
Local, State, County, City Governments
Indian/Native American Tribal Governments
Federal Agencies
Foreign Organizations
Active registration in System for Award Management (SAM)
Unique Entity Identifier (UEI)
eRA Commons account for Program Directors/Principal Investigators
Organizations from the US and foreign entities are eligible
Incorporation of novel technologies to accelerate cancer research
Interdisciplinary collaboration in developing innovative tools and methods
Independent validation of new technologies
Enhanced rigor of findings in cancer research
Skills and knowledge necessary to carry out proposed research
Application budgets may not exceed $150,000 in direct costs per year
Application due date: October 3, 2025
Compliance with NIH Grants Policy Statement
Adherence to data management and sharing policies
Follow instructions in the Research Instructions in the How to Apply - Application Guide